<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Stem Cell Investig</journal-id>
<journal-id journal-id-type="iso-abbrev">Stem Cell Investig</journal-id>
<journal-id journal-id-type="publisher-id">SCI</journal-id>
<journal-title-group>
<journal-title>Stem Cell Investigation</journal-title>
</journal-title-group>
<issn pub-type="ppub">2306-9759</issn>
<issn pub-type="epub">2313-0792</issn>
<publisher>
<publisher-name>AME Publishing Company</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29057252</article-id>
<article-id pub-id-type="pmc">5639011</article-id>
<article-id pub-id-type="publisher-id">sci-04-2017.09.01</article-id>
<article-id pub-id-type="doi">10.21037/sci.2017.09.01</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>GLIS1-3: emerging roles in reprogramming, stem and progenitor cell differentiation and maintenance</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Scoville</surname>
<given-names>David W.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kang</surname>
<given-names>Hong Soon</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Jetten</surname>
<given-names>Anton M.</given-names>
</name>
</contrib>
<aff id="aff1">Cell Biology Section, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, <institution>National Institutes of Health</institution>, <addr-line>Research Triangle Park, NC 27709</addr-line>, <country>USA</country></aff>
</contrib-group>
<author-notes>
<fn id="afn1">
<p><italic>Contributions:</italic> (I) Conception and design: All authors; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.</p>
</fn>
<corresp id="cor1"><italic>Correspondence to:</italic> Anton M. Jetten. Cell Biology Section, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA. Email: <email xlink:href="jetten@niehs.nih.gov">jetten@niehs.nih.gov</email>.</corresp>
<fn fn-type="COI-statement">
<p><italic>Conflicts of Interest</italic>: The authors have no conflicts of interest to declare.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>4</volume>
<elocation-id>80</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>8</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>2017 Stem Cell Investigation. All rights reserved.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Stem Cell Investigation.</copyright-holder>
</permissions>
<abstract>
<p>Recent studies have provided evidence for a regulatory role of GLI-similar (GLIS) transcription factors in reprogramming, maintenance and differentiation of several stem and progenitor cell populations. GLIS1, in conjunction with several other reprogramming factors, was shown to markedly increase the efficiency of generating induced pluripotent stem cells (iPSC) from somatic cells. GLIS2 has been reported to contribute to the maintenance of the pluripotent state in hPSCs. In addition, GLIS2 has a function in regulating self-renewal of hematopoietic progenitors and megakaryocytic differentiation. GLIS3 plays a critical role during the development of several tissues. GLIS3 is able to promote reprogramming of human fibroblasts into retinal pigmented epithelial (RPE) cells. Moreover, GLIS3 is essential for spermatogonial stem cell renewal and spermatogonial progenitor cell differentiation. During pancreas development, GLIS3 protein is first detectable in bipotent pancreatic progenitors and pro-endocrine progenitors and plays a critical role in the generation of pancreatic beta cells. Here, we review the current status of the roles of GLIS proteins in the maintenance and differentiation of these different stem and progenitor cells.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords: </title>
<kwd>GLI-similar (GLIS)</kwd>
<kwd>pluripotent stem cells</kwd>
<kwd>reprogramming</kwd>
<kwd>spermatogonial stem cells (SSCs)</kwd>
<kwd>hematopoietic stem cells (HSCs)</kwd>
<kwd>pancreatic beta cells</kwd>
<kwd>Kr√ºppel-like zinc finger protein</kwd>
<kwd>pancreas</kwd>
<kwd>transcription</kwd>
<kwd>diabetes</kwd>
<kwd>acute megakaryoblastic leukemia (AMKL)</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>